- Raw materials
- Alkalinizing agents
- Carbonate ion
Carbonate ion API Manufacturers & Suppliers
0 verified results
Total market transparency
Supplier trade data access
Buyer / supplier flow comparison
Commercial-scale Suppliers
Join our notification list by following this page.
Click the button below to find out more
Click the button below to switch over to the contract services area of Pharmaoffer.
Total market transparency
Supplier trade data access
Buyer / supplier flow comparison
Carbonate ion | CAS No: 3812-32-6 | GMP-certified suppliers
A medication that supports acid-base balance through its role as an inorganic electrolyte involved in physiological buffering and pH regulation processes.
Therapeutic categories
Product Snapshot
- Carbonate ion is utilized as an inorganic chemical reagent rather than a formulated pharmaceutical product
- Its applications primarily involve pH buffering and mineral balance in various therapeutic and industrial processes
- Currently, carbonate ion does not have formal approval status from regulatory agencies such as the FDA or EMA and is considered experimental in pharmaceutical contexts
Clinical Overview
Pharmacologically, carbonate ion is classified under several categories including alkalies, anions, carbon compounds, and electrolytes. It plays a critical role in maintaining acid-base balance, particularly in buffering systems within biological organisms. Mechanism of action or specific pharmacodynamics parameters have not been delineated for medicinal use given its experimental status and lack of direct drug application.
Key absorption, distribution, metabolism, and excretion (ADME) characteristics specific to carbonate ion as a pharmacological agent are not characterized. In biological systems, carbonate ions largely exist in equilibrium with bicarbonate and carbon dioxide, contributing to systemic pH regulation through metabolic and respiratory pathways.
Safety and toxicity profiles for pharmaceutical use have not been established. However, carbonate ions are generally recognized as safe in physiological concentrations, while excessive systemic alkalinity resulting from dysregulated carbonate levels can lead to metabolic disturbances. Due to the absence of approved medical indications or commercial drug formulations containing carbonate ion as an API, no specific branded products are associated with its therapeutic use.
For sourcing and quality considerations, pharmaceutical-grade carbonate ion must meet stringent purity criteria to avoid contamination with heavy metals or other inorganic impurities. Analytical verification of composition and compliance with relevant pharmacopeial standards is crucial for experimental or industrial applications. Suppliers should provide certificates of analysis confirming identity, purity, and physicochemical properties consistent with intended use in research or manufacturing environments.
Identification & chemistry
| Generic name | Carbonate ion |
|---|---|
| Molecule type | Small molecule |
| CAS | 3812-32-6 |
| UNII | 7UJQ5OPE7D |
| DrugBank ID | DB14531 |
Formulation & handling
- Carbonate ion is a small molecule with high water solubility, suitable for aqueous oral or injectable formulations. Its low LogP indicates limited lipophilicity, favoring hydrophilic environments in formulation. Stability considerations should include control of pH and avoidance of CO2 loss during handling.
Regulatory status
Carbonate ion is a type of Alkalinizing agents
Alkalinizing agents, a pharmaceutical API category, refers to a group of substances used to increase the pH (alkalinity) of a solution or body fluid. These agents play a crucial role in various medical applications, such as the treatment of acidosis, kidney disorders, and certain drug overdoses.
One commonly used alkalinizing agent is sodium bicarbonate, which is highly effective in raising the pH of blood and urine. It works by neutralizing excess acid and restoring the acid-base balance in the body. Sodium bicarbonate is often administered intravenously in emergency situations to rapidly correct severe acidosis.
Another alkalinizing agent, acetazolamide, is frequently employed in the treatment of glaucoma and certain types of epilepsy. By inhibiting carbonic anhydrase, acetazolamide reduces the production of bicarbonate ions, leading to a systemic decrease in pH. This mechanism is particularly useful in lowering the intraocular pressure associated with glaucoma.
Alkalinizing agents are also utilized in the management of certain drug toxicities. For instance, methotrexate, a chemotherapy medication, can cause severe toxicity if its elimination is hindered. Alkalinizing the urine with agents like sodium bicarbonate enhances methotrexate solubility, preventing the formation of toxic crystals in the kidneys.
In conclusion, alkalinizing agents are indispensable pharmaceutical APIs that help correct acid-base imbalances, treat specific medical conditions, and mitigate drug toxicities. Their diverse applications make them valuable tools in modern medicine.
